Viyash Scientific Limited (NSE:VIYASH) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St · 1d ago

Last week saw the newest second-quarter earnings release from Viyash Scientific Limited (NSE:VIYASH), an important milestone in the company's journey to build a stronger business. Results were roughly in line with estimates, with revenues of ₹9.9b and statutory earnings per share of ₹4.01. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

earnings-and-revenue-growth
NSEI:VIYASH Earnings and Revenue Growth November 17th 2026

Taking into account the latest results, the current consensus from Viyash Scientific's four analysts is for revenues of ₹40.0b in 2027. This would reflect an okay 7.6% increase on its revenue over the past 12 months. Per-share earnings are expected to soar 26% to ₹6.65. Yet prior to the latest earnings, the analysts had been anticipated revenues of ₹39.0b and earnings per share (EPS) of ₹8.35 in 2027. While next year's revenue estimates increased, there was also a pretty serious reduction to EPS expectations, suggesting the consensus has a bit of a mixed view of these results.

See our latest analysis for Viyash Scientific

There's been no major changes to the price target of ₹330, suggesting that the impact of higher forecast revenue and lower earnings won't result in a meaningful change to the business' valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values Viyash Scientific at ₹360 per share, while the most bearish prices it at ₹310. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Viyash Scientific is an easy business to forecast or the the analysts are all using similar assumptions.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that Viyash Scientific's revenue growth will slow down substantially, with revenues to the end of 2027 expected to display 16% growth on an annualised basis. This is compared to a historical growth rate of 20% over the past five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 12% annually. So it's pretty clear that, while Viyash Scientific's revenue growth is expected to slow, it's still expected to grow faster than the industry itself.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Viyash Scientific. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. The consensus price target held steady at ₹330, with the latest estimates not enough to have an impact on their price targets.

With that in mind, we wouldn't be too quick to come to a conclusion on Viyash Scientific. Long-term earnings power is much more important than next year's profits. We have forecasts for Viyash Scientific going out to 2029, and you can see them free on our platform here.

It is also worth noting that we have found 1 warning sign for Viyash Scientific that you need to take into consideration.